ArticleFrontiers in pediatrics2026
Clinical characteristics of adenotonsillar hypertrophy in children: a retrospective analysis.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the clinical characteristics of adenotonsillar hypertrophy (ATH) in children and determine its related clinical indicators. Methods: A retrospective cohort of 215 children with ATH who met predefined inclusion and exclusion criteria was identified from newly diagnosed patients presenting to the pediatric department of the study institution between March 1, 2024, and January 2025. Demographic characteristics, clinical data, and laboratory parameters were collected for subsequent univariate and multivariate analyses. Results: The cohort comprised 117 boys and 98 girls with a mean age of 5.81 ± 2.13 years, a mean tonsil-to-pharynx ratio (T/P ratio) of 0.60 ± 0.10, and a mean adenoid-to-nasopharynx ratio (A/N ratio) of 0.76 ± 0.08. Notably, A/N ratios differed significantly between children with and without snoring (0.78 ± 0.10 vs. 0.68 ± 0.04; Conclusion: Adenoid and tonsillar hypertrophy have distinct associated factors, and age, PLR, and LSaO₂ aid in assessing pediatric ATH severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.